Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Parkinsons Disease is the second most common neurological disorder. Over the course of the disease the brain cells that produce dopamine are slowly dying. The loss of these dopamine-producing cells means that less dopamine is available in the brain, causing many symptoms such as tremors. Unfortunately, brain cells cannot regenerate, so a patients symptoms will worsen over time. In the current project we aim to investigate human dopamine cells (i.e. drNPC-A9) that were grown in a petri-dish by New World Laboratories. Pre-clinical studies have revealed that the injection of these drNPC-A9 cells in rats, can rescue Parkinson disease-like symptoms. In this project we aim to understand how these drNPC-A9 cells are able to do that. The acquired information will directly contribute to the development of a therapy for Parkinsons Disease.
Louis-Eric Trudeau
Willemieke Kouwenhoven
New World Laboratories Inc
Pharmacy / Pharmacology
Medical devices
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.